{
  "question_stem": {
    "en": "Researchers studying fungal pathogens isolated an ergosterol biosynthetic gene by polymerase chain reaction. Using homologous recombination, they then developed a new strain of *Candida* with a mutated allele for that gene. The mutant strain was cultured in the presence of several different antifungal agents. Compared to isolates from the wild-type strain, isolates from the mutant *Candida* strain exhibited enhanced growth in the presence of drug X. Further investigation revealed that the mechanism of resistance to drug X was a decrease in ergosterol incorporation into the cell membrane. Based on this data, drug X is likely to be most closely related to which of the following antifungal agents?",
    "zh": "研究人员研究真菌病原体，通过聚合酶链式反应分离了麦角甾醇生物合成基因。利用同源重组，他们随后开发了一种新的 *Candida* 菌株，该菌株具有该基因的突变等位基因。将突变菌株在几种不同的抗真菌剂存在下培养。与来自野生型菌株的菌株相比，来自突变 *Candida* 菌株的菌株在药物 X 存在下表现出增强的生长。进一步研究表明，对药物 X 产生耐药性的机制是减少了麦角甾醇在细胞膜中的掺入。根据这些数据，药物 X 最有可能与以下哪种抗真菌剂相关？"
  },
  "question": {
    "en": "Based on this data, drug X is likely to be most closely related to which of the following antifungal agents?",
    "zh": "根据这些数据，药物 X 最有可能与以下哪种抗真菌剂相关？"
  },
  "options": {
    "A": {
      "en": "Caspofungin",
      "zh": "卡泊芬净"
    },
    "B": {
      "en": "Cyclosporine",
      "zh": "环孢素"
    },
    "C": {
      "en": "Flucytosine",
      "zh": "氟胞嘧啶"
    },
    "D": {
      "en": "Griseofulvin",
      "zh": "灰黄霉素"
    },
    "E": {
      "en": "Nystatin",
      "zh": "制霉素"
    }
  },
  "correct_answer": "E",
  "explanation": {
    "en": "Of these agents, only the polyenes (amphotericin B, nystatin) depend on the amount of ergosterol incorporated into fungal cell membranes for their efficacy. These drugs bind to ergosterol molecules, forming pores in the membrane and allowing leakage of ions (especially K+) from the cells. This disruption of cell membrane integrity leads to cell lysis. An organism that decreases the amount of ergosterol in its cell membrane would likely become resistant to polyenes. Amphotericin B is a systemic antifungal active against *Candida, Aspergillus, Cryptococcus, Histoplasma, Blastomyces,* and *Coccidioides*. Nystatin is used topically; oral candidiasis is the main indication for its use (\"swish and swallow\").\n\n(Choice A) Caspofungin is an antifungal agent that blocks synthesis of the glucan component of the fungal cell wall. It is active against *Candida* and *Aspergillus*. Caspofungin does not bind ergosterol.\n\n(Choice B) Cyclosporine is an immunosuppressant used in transplant recipients to prevent rejection. It decreases the synthesis of IL-2, thereby inhibiting T cell proliferation.\n\n(Choice C) Flucytosine is used in combination with amphotericin B primarily for the treatment of cryptococcal meningitis in patients with HIV. It is a nucleotide analog that competitively inhibits RNA synthesis in fungal cells.\n\n(Choice D) Griseofulvin interacts with fungal cell microtubules, inhibiting mitosis. It accumulates in keratin-containing tissues and is used to treat dermatophyte infections (eg, *Microsporum, Epidermophyton, Trichophyton*).\n\nEducational objective:\nThe main groups of antifungal drugs are polyenes, azoles, echinocandins, and pyrimidines. Polyene antifungals (eg, amphotericin B, nystatin) act by binding ergosterol in the fungal cell membrane.",
    "zh": "在这些药物中，只有多烯类药物（两性霉素 B、制霉素）的疗效取决于掺入真菌细胞膜中的麦角甾醇的量。这些药物与麦角甾醇分子结合，在细胞膜中形成孔，从而允许离子（尤其是 K+）从细胞中泄漏。这种对细胞膜完整性的破坏导致细胞溶解。减少细胞膜中麦角甾醇量的生物体很可能对多烯类药物产生耐药性。两性霉素 B 是一种全身性抗真菌药，对 *Candida、Aspergillus、Cryptococcus、Histoplasma、Blastomyces* 和 *Coccidioides* 有活性。制霉素局部使用；口腔念珠菌病是其主要适应症（“漱口并吞服”）。\n\n（选项 A）卡泊芬净是一种抗真菌剂，可阻断真菌细胞壁葡聚糖成分的合成。它对 *Candida* 和 *Aspergillus* 有活性。卡泊芬净不与麦角甾醇结合。\n\n（选项 B）环孢素是一种免疫抑制剂，用于移植受者以防止排斥反应。它减少 IL-2 的合成，从而抑制 T 细胞增殖。\n\n（选项 C）氟胞嘧啶主要与两性霉素 B 联合用于治疗 HIV 患者的隐球菌性脑膜炎。它是一种核苷类似物，可竞争性抑制真菌细胞中的 RNA 合成。\n\n（选项 D）灰黄霉素与真菌细胞微管相互作用，抑制有丝分裂。它积聚在含角蛋白的组织中，用于治疗皮肤癣菌感染（例如，*Microsporum, Epidermophyton, Trichophyton*）。\n\n教育目标：\n抗真菌药物的主要类别有多烯类、唑类、棘球素类和嘧啶类。多烯类抗真菌药（例如，两性霉素 B、制霉素）通过与真菌细胞膜中的麦角甾醇结合而发挥作用。"
  },
  "summary": {
    "en": "This question tests knowledge of antifungal medications and their mechanisms of action, specifically focusing on how they interact with ergosterol in the fungal cell membrane. It requires understanding which antifungal classes are affected by changes in ergosterol incorporation.\n\nThe key to solving this question is recognizing that the mutant Candida strain's resistance to drug X is due to decreased ergosterol incorporation. This implies that drug X likely targets ergosterol directly. By knowing which antifungal agents target ergosterol, the correct answer can be identified.",
    "zh": "本题考察对​抗真菌药物及其作用机制的了解，特别是侧重于它们如何与真菌细胞膜中的麦角甾醇相互作用。它需要理解哪些抗真菌药物类别受到麦角甾醇掺入变化的影响。\n\n解决这个问题的关键是认识到突变型念珠菌菌株对药物 X 的耐药性是由于麦角甾醇掺入减少。这意味着药物 X 可能会直接靶向麦角甾醇。通过了解哪些抗真菌剂靶向麦角甾醇，可以确定正确答案。"
  },
  "tags": "Antifungal agents; Ergosterol; Candida; Nystatin; Polyenes; Fungal resistance; Cell membrane; Microbiology; Infectious Diseases; Antimicrobial resistance",
  "category": "Micro",
  "question_id": "271",
  "has_exhibits": false,
  "exhibit_count": 0,
  "exhibit_files": [],
  "folder_path": "C:\\Datas\\usmle\\step1\\clip\\Micro 23\\271",
  "extracted_at": "2025-11-05T15:03:56.284102",
  "extraction_config": {
    "temperature": 0.1,
    "top_k": 1,
    "prompt_strategy": "standard"
  },
  "translated_at": "2025-11-07T18:11:49.220035",
  "translation_model": "gemini-2.0-flash-lite",
  "embedding_model": "models/embedding-001",
  "embedding_dimension": 768
}